SS

Steven Stacker

LR Ludwig Institute For Cancer Research: 11 patents #51 of 611Top 9%
VL Vegenics Limited: 7 patents #3 of 18Top 20%
HL Helsinki University Licensing: 3 patents #5 of 45Top 15%
VL Vegenics Pty Limited: 3 patents #4 of 30Top 15%
PI Peter Maccallum Cancer Institute: 1 patents #9 of 46Top 20%
UO University Of Otago: 1 patents #13 of 42Top 35%
Overall (All Time): #195,829 of 4,157,543Top 5%
22
Patents All Time

Issued Patents All Time

Showing 1–22 of 22 patents

Patent #TitleCo-InventorsDate
9862776 Antibodies against human RYK and uses therefor Maria Luisa Macheda, Michael Maurice Halford, Clare Louise Parish, Edouard Collins Nice 2018-01-09
8461109 Method of enhancing the acceptance and/or healing of a skin graft Marc G. Achen, Kari Alitalo 2013-06-11
8227410 Methods of stimulating wound healing by administration of vascular endothelial growth factor D (VEGF-D) Marc G. Achen, Andrew Frederick Wilks, Kari Alitalo 2012-07-24
7947472 Expression vectors and cell lines expressing vascular endothelial growth factor D Marc G. Achen, Kari Alitalo 2011-05-24
7928061 Methods of using VEGF-D polypeptides Marc G. Achen, Kari Alitalo, Andrew Frederick Wilks 2011-04-19
7871798 Mammalian cells that express VEGF-D polypeptides Marc G. Achen, Andrew Frederick Wilks, Kari Alitalo 2011-01-18
7846437 Chimeric anti-VEGF-D antibodies and humanized anti-VEGF-D antibodies and methods of using same Marc G. Achen, Christoph Renner 2010-12-07
7785803 Antibody diagnostic kits and methods of use Marc G. Achen, Kari Alitalo, Andrew Frederick Wilks 2010-08-31
7534572 Methods for treating neoplastic disease characterized by vascular endothelial growth factor D expression, for screening for neoplastic disease or metastatic risk, and for maintaining vascularization of tissue Marc G. Achen 2009-05-19
7479270 Methods and compositions for activating VEGF-D and VEGF-C Bradley McColl, Megan E. Baldwin, Marc G. Achen 2009-01-20
7410639 Vascular endothelial growth factor D(VEGF-D) antibodies and methods of use Marc G. Achen, Andrew Frederick Wilks, Kari Alitalo 2008-08-12
7122654 Vascular endothelial growth factor D (VEGF-D) antibodies and vectors, and methods of use Marc G. Achen, Andrew Frederick Wilks, Kari Alitalo 2006-10-17
7097986 Antibodies to truncated VEGF-D and uses thereof Marc G. Achen 2006-08-29
7045133 VEGF-D/VEGF-C/VEGF peptidomimetic inhibitor Marc G. Achen, Richard Hughes, Angela Cendron 2006-05-16
6730489 Antibodies to truncated VEGF-D and uses thereof Marc G. Achen 2004-05-04
6689352 Method for activating only the vascular endothelial growth factor receptor-3 and uses thereof Marc G. Achen 2004-02-10
6689580 Growth factor Marc G. Achen, Andrew Frederick Wilks, Kari Alitalo 2004-02-10
6541008 Vascular endothelial growth factor-like protein from orf viruses binds and activates mammalian VEGF receptor-2, and uses thereof Lyn Marie WISE, Andrew Mercer, Loreen J. Savory, Stephen Bruce Fleming 2003-04-01
6383484 Antibodies to truncated VEGF-D and thereof Marc G. Achen 2002-05-07
6235713 Vascular endothelial growth factor-D (VEGF-D) polypeptides Marc G. Achen, Andrew Frederick Wilks, Kari Alitalo 2001-05-22
6218516 Antibodies specific for the extracellular domain of NYK/flk-1 protein and uses thereof Andrew Frederick Wilks, Robert B Oelrichs 2001-04-17
6107472 Receptor-type tyrosine kinase-like molecules Christopher Hovens, Andrew Frederick Wilks 2000-08-22